^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Urodiag®

    Company:
    OncoDiag
    Type:
    CE Marked
    Related tests:

    Details

    Evidence
    News
    Urodiag® is an accurate urine-based test for the surveillance of patients with low-, intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC). Its a multiplex quantitative real-time PCR mutation assay that detects 4 mutations of the FGFR3 gene (G372C, R248C, S249C, Y375C) and Methylation assay: Quantification of the level of DNA methylation of HS3ST2, SEPTIN9 and SLIT2 genes.
    Cancer:
    Bladder Cancer
    Gene:
    FGFR3 (Fibroblast growth factor receptor 3), HS3ST2 (Heparan Sulfate-Glucosamine 3-Sulfotransferase 2), SEPTIN9 (Septin 9), SLIT2 (Slit Guidance Ligand 2)
    Method:
    Multiplex-PCR